Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of Blue Coat Systems, Inc. (“Blue Coat” or the “Company”) (NASDAQ: BCSI) concerning the proposed acquisition of Blue Coat by Thoma Bravo, LLC in a cash transaction valued at approximately $1.3 billion. The investigation concerns whether the board of directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms of the agreement, Blue Coat shareholders would receive $25.81 per share in cash. However, a research analyst has set a target share price of $28.00 per share. Moreover, Blue Coat traded higher than the offer price for a majority of the first two quarters of 2011, and has traded as high as $32. Blue Coat shareholders seeking more information about this acquisition are advised to contact Gustavo Bruckner, Esq. at email@example.com or 212-661-1100 or toll free at 888-476-6529, ext. 302. Shareholders may also contact Rachelle R. Boyle at firstname.lastname@example.org or 212-661-1100 or 888-476-6529, ext. 237. The Pomerantz Firm, with offices in New York, Chicago, and Washington, D.C., is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.